Hims & Hers Health, Inc. (HIMS) Outperforms Broader Market: What You Need to Know

Company Performance - Hims & Hers Health, Inc. (HIMS) closed at $58.68, marking a +1.79% move from the prior day, outperforming the S&P 500's daily gain of 0.02% [1] - The stock has risen by 16.68% in the past month, leading the Medical sector's gain of 1.92% and the S&P 500's gain of 4.93% [1] Upcoming Earnings - The company is scheduled to release its earnings on August 4, 2025, with projected earnings of $0.18 per share, representing year-over-year growth of 200% [2] - The consensus estimate for revenue is $551.84 million, reflecting a 74.83% rise from the equivalent quarter last year [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.75 per share and revenue of $2.35 billion, signifying shifts of +177.78% and +58.88% respectively from the last year [3] Analyst Estimates and Confidence - Recent revisions in analyst estimates reflect the latest near-term business trends, with positive revisions indicating analysts' confidence in the business performance and profit potential [3][4] Zacks Rank and Performance - Hims & Hers Health, Inc. currently possesses a Zacks Rank of 1 (Strong Buy), with the Zacks Rank system showing an impressive track record of outperformance [5] - Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.27% higher [5] Valuation Metrics - The company has a Forward P/E ratio of 77.22, which is a premium compared to the average Forward P/E of 27.59 for its industry [6] - HIMS has a PEG ratio of 2.13, compared to the average PEG ratio for the Medical Info Systems industry, which stood at 3.15 [7] Industry Overview - The Medical Info Systems industry is part of the Medical sector and currently holds a Zacks Industry Rank of 74, placing it in the top 30% of all 250+ industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]